VYERA PHARMACEUTICALS
Vyera Pharmaceuticals is focused on developing therapies specifically targeted to treat patients suffering from serious and neglected diseases with high unmet needs. Vyera supports programs that offer financial assistance to patients in need and provides discounts to organizations that provide care to underserved patients.
VYERA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.vyera.com
Total Employee:
101+
Status:
Active
Contact:
+1 212.202.5935
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving HSTS Google Google Cloud Microsoft Amazon S3 HSTS IncludeSubdomains PreLoad Ruby On Rails Token Ruby On Rails
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Promosome
Promosome is specialized in technologies related to the regulation of protein synthesis through translation initiation.
Sensory Health Systems
Sensory Health Systems is developing a real time continuous monitoring platform with initial focus on Cardiovascular conditions.
Current Employees Featured
Founder
Official Site Inspections
http://www.vyera.com Semrush global rank: 16.01 M Semrush visits lastest month: 1
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Vyera Pharmaceuticals"
Vyera Pharmaceuticals - Wikipedia
Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017. The company has two marketed products: Daraprim … See moreSee details»
Vyera Pharmaceuticals - Crunchbase Company Profile & Funding
Vyera is focused on developing novel treatment options for toxoplasmosis and other rare or …See details»
Infamous pharma company founded by Shkreli files for …
May 11, 2023 · The pharmaceutical company behind Martin Shkreli's infamous 4,000 percent …See details»
Vyera Pharmaceuticals - Craft
Vyera Pharmaceuticals is a company developing treatment options for toxoplasmosis and other …See details»
Vyera Pharmaceuticals Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Vyera …See details»
Vyera Pharmaceuticals - Overview, News & Similar companies
May 10, 2023 · Vyera Pharmaceuticals contact info: Phone number: (212) 202-5935 Website: …See details»
Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase ...
Aug 1, 2023 · Vyera supports programs that offer financial assistance to patients in need and …See details»
Shkreli's former company Vyera files for bankruptcy - Fierce Pharma
May 11, 2023 · Martin Shkreli’s former company Vyera Pharmaceuticals, once known as …See details»
Vyera Pharmaceuticals, LLC | LinkedIn
Vyera Pharmaceuticals, LLC | 1,649 followers on LinkedIn. Treating Serious and Neglected …See details»
Shkreli's former drug company to settle antitrust class action
Jan 28, 2022 · Shkreli, who ran Vyera as chief executive when it was known as Turing …See details»
U.S. FTC settles with Vyera over Daraprim, Shkreli trial still on
Dec 7, 2021 · Tuesday's settlement, worth up to $40 million, addressed claims in a Jan. 2020 …See details»
Vyera Pharmaceuticals - Contacts, Employees, Board Members
Vyera Pharmaceuticals has 3 current employee profiles, including Sr. Vice President, Head of …See details»
Vyera Pharmaceuticals, LLC Company Information - Drugs.com
Vyera Pharmaceuticals, LLC manufactures, markets and/or distributes more than 2 drugs in …See details»
Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera …
Dec 7, 2023 · Tilde Sciences expects a seamless transition from Vyera Pharmaceuticals and …See details»
Remedies in FTC's Vyera Case Create Strict Standard for …
Jan 31, 2022 · In January 2020, the FTC and the New York Attorney General jointly sued …See details»
FTC Announces $40 Million Settlement with Vyera Pharmaceuticals
Dec 13, 2021 · The complaint alleges that Shkreli and Mulleady started Vyera with a plan to …See details»
U.S. FTC settles with Vyera over Daraprim, Shkreli trial still on
Dec 7, 2021 · Tuesday's settlement, worth up to $40 million, addressed claims in a Jan. 2020 …See details»
Vyera Pharmaceuticals | Biotech Careers
Vyera Pharmaceuticals is committed to developing and commercializing treatments that …See details»
Vyera Pharmaceuticals Receives FDA Clearance To Initiate A Phase …
NEW YORK, Nov. 15, 2018 /PRNewswire/ -- Vyera Pharmaceuticals, LLC (Vyera) announced …See details»
AHLA - Vyera Pharmaceuticals to Pay up to $40 Million to Resolve ...
Vyera Pharmaceutical LLC will pay up to $40 million to resolve a federal and state lawsuit …See details»